Pregnant Women Experiencing Zofran Side Effects And Birth Defects
Although several Zofran related side effects have been noted over the years, only recently has the drug been associated with serious birth defects. The drug, also known by its trade name ondansetron, was never intended to be used in pregnant women, and in fact, it still isn’t approved for use in expecting mothers. It was approved for use in patients recovering from surgery, chemotherapy, or radiotherapy in 1991, but its manufacturer, GlaxoSmithKline, soon put profits over people when marketing the medication.
The company pushed doctors into prescribing it to pregnant women to ward off morning sickness, and while it is effective at doing that, the drug has been strongly linked to many serious birth defects. These include cleft palate deformations, congenital heart defects, slowed development, and even intrauterine fetal death. These severe Zofran related birth defects have been revealed in recent studies, but GlaxoSmithKline was at least aware of their possibility back in the 80s when it performed animal fetal testing. Their findings echo what researchers now understand about the drug.
This combination of deceptive marketing and lack of proper safety protocols has meant a lot of pain and suffering for families around the country. As a result, GlaxoSmithKline will pay out billions in penalties and settlements to families harmed by the medication. Any family hurt by the drug is encouraged to review their options for legal representation, as settlement negotiations are ongoing.